Immune Response and Potential Booster for Patients Who Have Received HER2-pulsed DC1

Clinical trial NCT03630809 · TERMINATED

Trial details

NCT number: NCT03630809
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer HER2-positive Breast Cancer HER-2 Gene Amplification HER2 Positive Breast Carcinoma HER-2 Protein Overexpression Breast Cancer, Male Breast Cancer Female

Start date: 2019-01-10
Primary completion: 2022-04-11
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.